These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 10094103
1. Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery. Bernini G, Moretti A, Lonzi S, Bendinelli C, Miccoli P, Salvetti A. Metabolism; 1999 Mar; 48(3):298-300. PubMed ID: 10094103 [Abstract] [Full Text] [Related]
2. The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism. Kovács L, Góth MI, Szabolcs I, Dohán O, Ferencz A, Szilágyi G. Eur J Endocrinol; 1998 May; 138(5):543-7. PubMed ID: 9625366 [Abstract] [Full Text] [Related]
3. Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism. Kono K, Fujii H, Watanabe K, Goto S, Nishi S. J Bone Miner Metab; 2021 Mar; 39(2):230-236. PubMed ID: 32920706 [Abstract] [Full Text] [Related]
4. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Gennari C, Nami R, Gonnelli S. Miner Electrolyte Metab; 1995 Mar; 21(1-3):77-81. PubMed ID: 7565468 [Abstract] [Full Text] [Related]
5. Urinary free cortisol is not a biochemical marker of hypertension. Krall P, Carvajal C, Ortiz E, Muñoz C, Garrido JL, Mosso L, Fardella C. Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356 [Abstract] [Full Text] [Related]
6. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system. Muller ME, Forni Ogna V, Maillard M, Stoudmann C, Zweiacker C, Anex C, Wuerzner G, Burnier M, Bonny O. Pflugers Arch; 2015 Dec; 467(12):2413-21. PubMed ID: 26089029 [Abstract] [Full Text] [Related]
7. Aldosterone Secretion in Patients With Primary Hyperparathyroidism Without Arterial Hypertension. Castellano E, Pellegrino M, Tardivo V, Attanasio R, Boriano A, Borretta G. Endocr Pract; 2021 Nov; 27(11):1072-1076. PubMed ID: 33965584 [Abstract] [Full Text] [Related]
9. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension. Iimura O, Kikuchi K, Shimamoto K, Nozawa A, Hasegawa R, Homma C, Komura H, Kobayakawa H. Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339 [Abstract] [Full Text] [Related]
10. Effect of intravenous calcium infusion on indices of activity of the parathyroid glands and on urinary calcium and sodium excretion in normotensive and hypertensive subjects. Papagalanis N, Kourti A, Tolis A, Skopelitis P, Karabatsos A, Kostoyanni G, Gennadiou M, Elisaf M, Mountokalakis T. Am J Hypertens; 1993 Jan; 6(1):59-65. PubMed ID: 8427663 [Abstract] [Full Text] [Related]
11. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, Meinitzer A, März W, Pieber TR, Tomaschitz A. J Clin Endocrinol Metab; 2012 Jan; 97(1):E75-9. PubMed ID: 22013107 [Abstract] [Full Text] [Related]
12. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH. Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782 [Abstract] [Full Text] [Related]
14. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects. Schlaich MP, Klingbeil A, Hilgers K, Schobel HP, Schmieder RE. Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810 [Abstract] [Full Text] [Related]
15. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial. Verheyen N, Fahrleitner-Pammer A, Pieske B, Meinitzer A, Belyavskiy E, Wetzel J, Gaksch M, Grübler MR, Catena C, Sechi LA, Van Ballegooijen AJ, Brandenburg VM, Scharnagl H, Perl S, Brussee H, März W, Pilz S, Tomaschitz A. J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537 [Abstract] [Full Text] [Related]
18. Changes of hormones regulating electrolyte metabolism after space flight and hypokinesia. Macho L, Fickova M, Lichardus B, Kvetnansky R, Carrey RM, Grigoriev A, Popova IA, Tigranian RA, Noskov VB. Acta Astronaut; 1992 Jul; 27():51-4. PubMed ID: 11537597 [Abstract] [Full Text] [Related]
19. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. van den Born BJ, Koopmans RP, van Montfrans GA. Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041 [Abstract] [Full Text] [Related]
20. [Plasma renin activity, aldosterone and adrenergic activity in patients with hypertension and in normotensives with a family history of hypertension]. Cybulska I, Januszak-Sitkowska H, Peczkowska M, Pszona B, Sznajderman M. Pol Arch Med Wewn; 1996 Feb; 95(2):111-24. PubMed ID: 8677205 [Abstract] [Full Text] [Related] Page: [Next] [New Search]